Default: BMC Cancer

ISSN:

Journal Home

Journal Guideline

BMC Cancer Q2 Unclaimed

BioMed Central Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

BMC Cancer is a journal indexed in SJR in Genetics and Oncology with an H index of 129. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2390 €. The scope of the journal is focused on cancer. It has an SJR impact factor of 1,358 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,358.

BMC Cancer focuses its scope in these topics and keywords: cancer, breast, patients, cell, human, ovarian, study, expression, cells, growth, ...

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

2390 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

BMC Cancer

1,358

SJR Impact factor

129

H Index

1205

Total Docs (Last Year)

3427

Total Docs (3 years)

45155

Total Refs

14037

Total Cites (3 years)

3423

Citable Docs (3 years)

4,07

Cites/Doc (2 years)

37,47

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, breast, patients, cell, human, ovarian, study, expression, cells, growth, therapy, carcinoma, lung, women, colorectal, tumor, dna, pathway, increases, lymph, melanoma, effects, prostate, squamous, advanced, cancer

FAQS